281 related articles for article (PubMed ID: 22053823)
1. HMGA1 drives stem cell, inflammatory pathway, and cell cycle progression genes during lymphoid tumorigenesis.
Schuldenfrei A; Belton A; Kowalski J; Talbot CC; Di Cello F; Poh W; Tsai HL; Shah SN; Huso TH; Huso DL; Resar LM
BMC Genomics; 2011 Nov; 12():549. PubMed ID: 22053823
[TBL] [Abstract][Full Text] [Related]
2. The High Mobility Group A1 (HMGA1) Transcriptome in Cancer and Development.
Sumter TF; Xian L; Huso T; Koo M; Chang YT; Almasri TN; Chia L; Inglis C; Reid D; Resar LM
Curr Mol Med; 2016; 16(4):353-93. PubMed ID: 26980699
[TBL] [Abstract][Full Text] [Related]
3. The high-mobility group A1a/signal transducer and activator of transcription-3 axis: an achilles heel for hematopoietic malignancies?
Hillion J; Dhara S; Sumter TF; Mukherjee M; Di Cello F; Belton A; Turkson J; Jaganathan S; Cheng L; Ye Z; Jove R; Aplan P; Lin YW; Wertzler K; Reeves R; Elbahlouh O; Kowalski J; Bhattacharya R; Resar LM
Cancer Res; 2008 Dec; 68(24):10121-7. PubMed ID: 19074878
[TBL] [Abstract][Full Text] [Related]
4. The high mobility group A1 gene: transforming inflammatory signals into cancer?
Resar LM
Cancer Res; 2010 Jan; 70(2):436-9. PubMed ID: 20068164
[TBL] [Abstract][Full Text] [Related]
5. The High Mobility Group A1 (HMGA1) gene is highly overexpressed in human uterine serous carcinomas and carcinosarcomas and drives Matrix Metalloproteinase-2 (MMP-2) in a subset of tumors.
Hillion J; Roy S; Heydarian M; Cope L; Xian L; Koo M; Luo LZ; Kellyn K; Ronnett BM; Huso T; Armstrong D; Reddy K; Huso DL; Resar LMS
Gynecol Oncol; 2016 Jun; 141(3):580-587. PubMed ID: 27001612
[TBL] [Abstract][Full Text] [Related]
6. High mobility group A1 and cancer: potential biomarker and therapeutic target.
Shah SN; Resar LM
Histol Histopathol; 2012 May; 27(5):567-79. PubMed ID: 22419021
[TBL] [Abstract][Full Text] [Related]
7. Inactivation of the Cdkn2a locus cooperates with HMGA1 to drive T-cell leukemogenesis.
Di Cello F; Dhara S; Hristov AC; Kowalski J; Elbahloul O; Hillion J; Roy S; Meijerink JP; Winter SS; Larson RS; Huso DL; Resar L
Leuk Lymphoma; 2013 Aug; 54(8):1762-8. PubMed ID: 23311322
[TBL] [Abstract][Full Text] [Related]
8. HMGA1 induces intestinal polyposis in transgenic mice and drives tumor progression and stem cell properties in colon cancer cells.
Belton A; Gabrovsky A; Bae YK; Reeves R; Iacobuzio-Donahue C; Huso DL; Resar LM
PLoS One; 2012; 7(1):e30034. PubMed ID: 22276142
[TBL] [Abstract][Full Text] [Related]
9. Lessons from the Crypt: HMGA1-Amping up Wnt for Stem Cells and Tumor Progression.
Resar L; Chia L; Xian L
Cancer Res; 2018 Apr; 78(8):1890-1897. PubMed ID: 29618461
[TBL] [Abstract][Full Text] [Related]
10. Dominant-negative c-Jun (TAM67) target genes: HMGA1 is required for tumor promoter-induced transformation.
Dhar A; Hu J; Reeves R; Resar LM; Colburn NH
Oncogene; 2004 May; 23(25):4466-76. PubMed ID: 15064752
[TBL] [Abstract][Full Text] [Related]
11. HMGA1 amplifies Wnt signalling and expands the intestinal stem cell compartment and Paneth cell niche.
Xian L; Georgess D; Huso T; Cope L; Belton A; Chang YT; Kuang W; Gu Q; Zhang X; Senger S; Fasano A; Huso DL; Ewald AJ; Resar LMS
Nat Commun; 2017 Apr; 8():15008. PubMed ID: 28452345
[TBL] [Abstract][Full Text] [Related]
12. Upregulation of MMP-2 by HMGA1 promotes transformation in undifferentiated, large-cell lung cancer.
Hillion J; Wood LJ; Mukherjee M; Bhattacharya R; Di Cello F; Kowalski J; Elbahloul O; Segal J; Poirier J; Rudin CM; Dhara S; Belton A; Joseph B; Zucker S; Resar LM
Mol Cancer Res; 2009 Nov; 7(11):1803-12. PubMed ID: 19903768
[TBL] [Abstract][Full Text] [Related]
13. HMGA1: a master regulator of tumor progression in triple-negative breast cancer cells.
Shah SN; Cope L; Poh W; Belton A; Roy S; Talbot CC; Sukumar S; Huso DL; Resar LM
PLoS One; 2013; 8(5):e63419. PubMed ID: 23658826
[TBL] [Abstract][Full Text] [Related]
14. HMGA1 down-regulation is crucial for chromatin composition and a gene expression profile permitting myogenic differentiation.
Brocher J; Vogel B; Hock R
BMC Cell Biol; 2010 Aug; 11():64. PubMed ID: 20701767
[TBL] [Abstract][Full Text] [Related]
15. HMGA1 reprograms somatic cells into pluripotent stem cells by inducing stem cell transcriptional networks.
Shah SN; Kerr C; Cope L; Zambidis E; Liu C; Hillion J; Belton A; Huso DL; Resar LM
PLoS One; 2012; 7(11):e48533. PubMed ID: 23166588
[TBL] [Abstract][Full Text] [Related]
16. High mobility group A1 (HMGA1) protein and gene expression correlate with ER-negativity and poor outcomes in breast cancer.
Gorbounov M; Carleton NM; Asch-Kendrick RJ; Xian L; Rooper L; Chia L; Cimino-Mathews A; Cope L; Meeker A; Stearns V; Veltri RW; Bae YK; Resar LMS
Breast Cancer Res Treat; 2020 Jan; 179(1):25-35. PubMed ID: 31531802
[TBL] [Abstract][Full Text] [Related]
17. Overexpression of HMGA1 deregulates tumor growth via cdc25A and alters migration/invasion through a cdc25A-independent pathway in medulloblastoma.
Lau KM; Chan QK; Pang JC; Ma FM; Li KK; Yeung WW; Cheng AS; Feng H; Chung NY; Li HM; Zhou L; Wang Y; Mao Y; Ng HK
Acta Neuropathol; 2012 Apr; 123(4):553-71. PubMed ID: 22249617
[TBL] [Abstract][Full Text] [Related]
18. Translating Proteomic Into Functional Data: An High Mobility Group A1 (HMGA1) Proteomic Signature Has Prognostic Value in Breast Cancer.
Maurizio E; Wiśniewski JR; Ciani Y; Amato A; Arnoldo L; Penzo C; Pegoraro S; Giancotti V; Zambelli A; Piazza S; Manfioletti G; Sgarra R
Mol Cell Proteomics; 2016 Jan; 15(1):109-23. PubMed ID: 26527623
[TBL] [Abstract][Full Text] [Related]
19. HMGA1 chromatin regulators induce transcriptional networks involved in GATA2 and proliferation during MPN progression.
Li L; Kim JH; Lu W; Williams DM; Kim J; Cope L; Rampal RK; Koche RP; Xian L; Luo LZ; Vasiljevic M; Matson DR; Zhao ZJ; Rogers O; Stubbs MC; Reddy K; Romero AR; Psaila B; Spivak JL; Moliterno AR; Resar LMS
Blood; 2022 May; 139(18):2797-2815. PubMed ID: 35286385
[TBL] [Abstract][Full Text] [Related]
20. High Mobility Group A1 (HMGA1): Structure, Biological Function, and Therapeutic Potential.
Wang L; Zhang J; Xia M; Liu C; Zu X; Zhong J
Int J Biol Sci; 2022; 18(11):4414-4431. PubMed ID: 35864955
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
